Frequent conversion of tuberculosis screening tests during anti-tumour necrosis factor therapy in patients with rheumatic diseases-Reference-Cited by-同舟云学术

Frequent conversion of tuberculosis screening tests during anti-tumour necrosis factor therapy in patients with rheumatic diseases

Published:2014-05-22 Issue:10 Volume:74 Page:1848-1853
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Ann Rheum Dis

Author:

Hatzara Chrisoula,Hadziyannis Emilia,Kandili Anna,Koutsianas Christos,Makris Anastasia,Georgiopoulos Georgios,Vassilopoulos Dimitrios

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Reference27 articles.

1. Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2012;Furst;Ann Rheum Dis,2013

2. 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis;Singh;Arthritis Care Res (Hoboken),2012

3. You can't always get what you want, but if you try sometimes (with two tests—TST and IGRA—for tuberculosis) you get what you need;Winthrop;Ann Rheum Dis,2012

4. Comparison of two gamma interferon release assays and tuberculin skin testing for tuberculosis screening in a cohort of patients with rheumatic diseases starting anti-tumor necrosis factor therapy;Vassilopoulos;Clin Vaccine Immunol,2011

5. Usefulness of enzyme-linked immunospot assay (Elispot) compared to tuberculin skin testing for latent tuberculosis screening in rheumatic patients scheduled for anti-tumor necrosis factor treatment;Vassilopoulos;J Rheumatol,2008

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tuberculin skin test repetition after TNF-α inhibitors in patients with chronic inflammatory arthritis: a long-term retrospective cohort in endemic area;Advances in Rheumatology;2024-09-13

2. Is yearly interferon gamma release assay latent tuberculosis infection screening warranted among patients with rheumatological diseases on disease-modifying drugs in non-endemic settings?;PLOS ONE;2024-07-03

3. Aktualisierte S3-Leitlinie Colitis ulcerosa (Version 6.2);Zeitschrift für Gastroenterologie;2024-05

4. Aktualisierte S3-Leitlinie Colitis ulcerosa (Version 6.1) – Februar 2023 – AWMF-Registriernummer: 021-009;Zeitschrift für Gastroenterologie;2023-08

5. Anti-tumor Necrosis Factor-α Antagonists and Tuberculosis;Integrated Science;2023